Analyst Research: Acorda Therapeutics Inc (ACOR.O)


ACOR.O on Nasdaq

34.22USD
17 Jun 2013
Price Change (% chg)

$0.19 (+0.56%)
Prev Close
$34.03
Open
$34.35
Day's High
$34.46
Day's Low
$33.65
Volume
229,575
Avg. Vol
447,039
52-wk High
$40.87
52-wk Low
$21.33

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Trading Report for (ACOR). A detailed report, including free correlated market analysis, and updates. 17 Jun 2013 Stock Traders Daily 5 58.00
The Investment Rate - a measure of investment demand. 17 Jun 2013 Stock Traders Daily 43 495.00
Thomson Reuters Stock Report - ACORDA THERAPEUTICS, INC. (ACOR-O) 17 Jun 2013 Thomson Reuters Stock Report 12 25.00
ACORDA THERAPTUTICS INC (ACOR) 12-months forecast 14 Jun 2013 Pechala's Reports 1 15.00
Acorda Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 14 Jun 2013 Reuters Investment Profile 12 20.00
Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ACORDA THERAPEUTICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 13 Jun 2013 Jefferson Research 11 20.00
ValuEngine Detailed Valuation Report for ACOR 12 Jun 2013 ValuEngine, Inc. 11 127.00
TheStreet.com Ratings Stock Report For: ACORDA THERAPEUTICS INC (ACOR) 8 Jun 2013 TheStreet.com Ratings 5 10.00
 

People

Name Age Since Current Position

Ronald Cohen

 56 President,Chief Executive Officer, Director

David Lawrence

 53 2005 Chief Financial Officer

Lauren Sabella

 50 2010 Executive Vice President - Commercial Development

Andrew Blight

 60 2004 Chief Scientific Officer

Jane Wasman

 54 2012 President - International, General Counsel, Corporate Secretary
» More People

Acorda Therapeutics Inc News

Search Stocks